» Articles » PMID: 15184433

Serological and Genetic Diversity of Capsular Polysaccharides in Enterococcus Faecalis

Overview
Specialty Microbiology
Date 2004 Jun 9
PMID 15184433
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Enterococci possess capsular carbohydrate antigens that are targets of opsonic antibodies. These antigens may be used to develop alternative options for the treatment and prevention of enterococcal infections. The present study was done to analyze the diversity of capsular polysaccharides in Enterococcus faecalis. Four type-specific sera were used in an enzyme-linked immunosorbent assay format to detect polysaccharide antigen extracted from bacterial cell walls. A total of 55% of a collection of 29 E. faecalis strains could be grouped into one of four serogroups. Additional analysis of the strains by opsonophagocytic assays revealed agreement between the results of the two methods for 72% of the isolates. An additional four strains could be assigned to a serogroup on the basis of opsonic killing by sera with antibodies against the four prototypes strains, provisionally named CPS-A to CPS-D. The results of the two methods disagreed for one strain (4%). When the results of both methods were combined, 66% of the strains could be classified. One strain had to be assigned to two serogroups. The assignments to the four serogroups were confirmed by analysis of the genetic organization of the biosynthetic capsular polysaccharide (cps) locus. All strains grouped into serotypes CPS-A and CPS-B possessed only the cpsA and cpsB genes, while all strains grouped into serogroups CPS-C and CPS-D possessed an additional eight or nine genes. Our results suggest the existence of a limited number of E. faecalis capsule serotypes, and we provisionally propose four serotypes, named CPS-A to CPS-D, and the respective prototype strains for these families.

Citing Articles

: an overlooked cell invader.

Archambaud C, Nunez N, da Silva R, Kline K, Serror P Microbiol Mol Biol Rev. 2024; 88(3):e0006924.

PMID: 39239986 PMC: 11426025. DOI: 10.1128/mmbr.00069-24.


Multidrug-resistant Enterococcus faecium strains enter the Norwegian marine environment through treated sewage.

Radisic V, Grevskott D, Junghardt N, Ovreas L, Marathe N Microbiologyopen. 2024; 13(2):e1397.

PMID: 38441345 PMC: 10913173. DOI: 10.1002/mbo3.1397.


Genomic Insights of UC7251, a Multi-Drug Resistant Strain From Ready-to-Eat Food, Highlight the Risk of Antimicrobial Resistance in the Food Chain.

Belloso Daza M, Milani G, Cortimiglia C, Pietta E, Bassi D, Cocconcelli P Front Microbiol. 2022; 13:894241.

PMID: 35814695 PMC: 9262338. DOI: 10.3389/fmicb.2022.894241.


Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy.

Tamai Y, Iwasa M, Eguchi A, Shigefuku R, Kamada Y, Miyoshi E JGH Open. 2021; 5(7):827-830.

PMID: 34263080 PMC: 8264230. DOI: 10.1002/jgh3.12596.


Inactivation of GalU Leads to a Cell Wall-Associated Polysaccharide Defect That Reduces the Susceptibility of Enterococcus faecalis to Bacteriolytic Agents.

Kurushima J, Tomita H Appl Environ Microbiol. 2021; 87(7).

PMID: 33483312 PMC: 8091619. DOI: 10.1128/AEM.02875-20.


References
1.
Xu Y, Singh K, Qin X, Murray B, Weinstock G . Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun. 2000; 68(2):815-23. PMC: 97210. DOI: 10.1128/IAI.68.2.815-823.2000. View

2.
Sharpe M . SEROLOGICAL TYPES OF STREPTOCOCCUS FAECALIS AND ITS VARIETIES AND THEIR CELL WALL TYPE ANTIGEN. J Gen Microbiol. 1964; 36:151-60. DOI: 10.1099/00221287-36-1-151. View

3.
Huebner J, Quaas A, Krueger W, Goldmann D, Pier G . Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000; 68(8):4631-6. PMC: 98395. DOI: 10.1128/IAI.68.8.4631-4636.2000. View

4.
Cetinkaya Y, Falk P, Mayhall C . Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000; 13(4):686-707. PMC: 88957. DOI: 10.1128/CMR.13.4.686. View

5.
. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control. 2000; 28(6):429-48. DOI: 10.1067/mic.2000.110544. View